Company Overview
- Headquarters
- 151 Oyster Point Blvd, South San Francisco CA
- Website
- cytomx.com
- Phone
- (650) 515-3185
- Employees
- 174
- Founded in
- 2008
- Industry
- BioTech/Drugs
- Stock Symbol
- NASDAQ:CTM
- NAICS Code
-
NAICS Code 3254 CompaniesNAICS Code 325 CompaniesNAICS Code 32 CompaniesNAICS Code 32541 Companies
- SIC Code
-
SIC Code 28 CompaniesSIC Code 283 Companies
Financials & Stats
Revenue
$71B
Total Funding Amount
$341M
Who is CytomX Therapeutics
CytomX Therapeutics, Inc. is a biotechnology company based in South San Francisco, California. Employing 125 people, the company has generated $50 million in revenue. CytomX focuses on developing novel cancer therapies through its Probody® platform. This platform has resulted in a diverse pipeline of five clinical-stage programs, with additional programs in development. The company is dedicated to creating safer and more effective treatments for patients. CytomX emphasizes a collaborative and inclusive work environment that values diversity, equity, and inclusion. The company is committed to ethical practices and believes its diverse perspectives contribute to scientific innovation and improving patient outcomes. For more information about CytomX Therapeutics and its groundbreaking work in cancer treatment, visit www.cytomx.com.
Company Leadership
CytomX Therapeutics Industry Tags
CytomX Therapeutics Tech Stack
Companies Similar to CytomX Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to CytomX Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 71M | 314 | Lexington, MA | 2015 | |
| 70M | 353 | Woburn, MA | 2015 | |
| 68M | 5 | Alpharetta, GA | 2012 | |
| 65M | 194 | San Jose, CA | 2004 | |
| 64M | 210 | Watertown, MA | 2016 |